Using a mouse model of liver IRI, we compared the effects of a GPR120 agonist with those of Omegaven庐.
GPR120 in liver was located to Kupffer cells (KCs). Agonist and Omegaven庐 provided similar protection from IRI, which was abolished by clodronate-depletion of KCs or by pretreatment with an 伪Gpr120-siRNA. In vitro and in vivo, both agents dampened the NF魏B/JNK-mediated inflammatory response. Dampening was associated with an M1>M2 macrophage polarization shift as assessed by marker expression. In 伪Gpr120-siRNA-pretreated mice with or without ischemia, Omegaven庐 was no more able to promote M2 marker expression, indicating its anti-inflammatory properties are dependent on GPR120 in liver.
These findings establish KC-GPR120 as a key mediator of Omegaven庐 effects and suggest GPR120 as a therapeutic target to mitigate inflammatory stress in liver.